Your provider can help determine a schedule that best fits your wellness goals
What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
Protects your heart and arteries
Together with folate, vitamin B12 is essential to the synthesis of DNA and red blood cells
(Commercial Product) Available Dosage Strengths 1,000 mcg/mL Want to Prescribe
Patients should be reviewed 812 weeks after commencing treatment to assess: Symptomatic improvement, particularly resolution of fatigue and neurological symptoms Haematological response (normalisation of haemoglobin and mean cell volume) Reticulocyte count typically rises within one week, indicating bone marrow response Repeat serum B12 testing is generally not useful after starting parenteral therapy, as levels remain elevated for months